Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable continued listing requirements of NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of the delisting of the Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Double Eagle Acquisition Corp.), Subscription Agreement (WillScot Corp)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable NASDAQ continued listing requirements of NASDAQrequirements. There are no proceedings pending or, to the Company’s knowledgeKnowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of of, nor to the Company’s Knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Selecta Biosciences Inc), Securities Purchase Agreement (Selecta Biosciences Inc)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, (a) the Company is in compliance with all applicable NASDAQ Capital Market (the “NASDAQ”) continued listing requirements of NASDAQ. There requirements, (b) there are no proceedings pending or, to the Company’s knowledgeKnowledge, threatened against the Company relating to the continued listing of the Company Common Stock on NASDAQ NASDAQ, and (c) the Company has not received any currently pending notice of the delisting of the Company Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Merger Agreement (Sphere 3D Corp), Merger Agreement (Overland Storage Inc)
Compliance with Nasdaq Continued Listing Requirements. The Company is in material compliance with all applicable NASDAQ National Market continued listing requirements of NASDAQand is in good standing on such exchange. There are no proceedings pending or, to the Company’s 's knowledge, threatened against the Company relating to the continued listing of the Common Stock on the NASDAQ National Market and the Company has not received any currently pending notice of, nor to the knowledge of the Company is there any basis for, the delisting of the Common Stock from NASDAQthe NASDAQ National Market.
Appears in 2 contracts
Samples: Amendment, Redemption and Exchange Agreement (Genome Therapeutics Corp), Amendment, Redemption and Exchange Agreement (Genome Therapeutics Corp)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Documents, the Company is in compliance with all applicable NASDAQ continued listing requirements of NASDAQrequirements. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of of, nor to the Company’s knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.
Appears in 1 contract
Samples: Securities Purchase Agreement (Bellerophon Therapeutics, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable continued listing requirements of the NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on the NASDAQ and the Company has not received any currently pending notice of the delisting of the Common Stock from the NASDAQ.
Appears in 1 contract
Samples: Stock Purchase Agreement (KalVista Pharmaceuticals, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable NASDAQ continued listing requirements of NASDAQrequirements. There are no proceedings pending or, to the Company’s knowledgeKnowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of of, nor, to the Company’s Knowledge, is there any reasonable basis for, the delisting of the Common Stock from NASDAQNASDAQ that has not been remedied.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable continued listing requirements of NASDAQThe NASDAQ Stock Market. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Company Common Stock on The NASDAQ Global Market and the Company has not received any currently pending notice of the delisting of the Common Stock from NASDAQThe NASDAQ Global Market.
Appears in 1 contract
Samples: Purchase Agreement (Glu Mobile Inc)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable NASDAQ Stock Market, LLC continued listing requirements of NASDAQrequirements. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on The NASDAQ Global Select Market and the Company has not received any currently pending notice of of, nor to the Company’s knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQThe NASDAQ Global Select Market.
Appears in 1 contract
Samples: Securities Purchase Agreement (Aimmune Therapeutics, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Documents, the Company is in compliance with all applicable NASDAQ continued listing requirements of NASDAQrequirements. There are no proceedings pending or, to the Company’s 's knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of of, nor to the Company's knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.
Appears in 1 contract
Samples: Securities Purchase Agreement (Puissance Cross-Border Opportunities III LLC)
Compliance with Nasdaq Continued Listing Requirements. The Except as set forth in the Reference SEC Reports, the Company is in compliance with all applicable NASDAQ continued listing requirements of NASDAQrequirements. There Except as set forth in the Reference SEC Reports, there are no proceedings pending or, to the knowledge of the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of, nor to the knowledge of the Company is there any basis for, the delisting of the Common Stock from NASDAQ.
Appears in 1 contract